Abiopharma

Clinical trial NCT05966467 updates: 1. completion date: 2030-03-01 → 2029-09-27 2. primary completion date: 2030-03-01 → 2029-09-27

Clinical trial NCT06982846 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-05-01 → 2026-05-04 3. primary completion date: 2026-05-01 → 2026-05-04 4. enrollment: 78 → 80 participants 5. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT06052631: start date: 2026-06-22 → 2026-06-23.

Clinical trial NCT04986579 updates: 1. completion date: 2028-06-01 → 2030-06-01 2. primary completion date: 2026-06-01 → 2028-06-01

Clinical trial NCT07473726 updates: 1. start date: 2026-05-17 → 2026-06-20 2. allocation: NON_RANDOMIZED → NA

Clinical trial NCT06104566: primary completion date: 2025-10-20 → 2026-12-31.

Clinical trial NCT05514717 updates: 1. status: RECRUITING → TERMINATED 2. completion date: 2027-04-01 → 2026-05-22 3. primary completion date: 2027-04-01 → 2026-05-22 4. enrollment: 162 → 57 participants 5. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT01897688 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2027-03-01 → 2025-02-01 3. primary completion date: 2025-03-01 → 2021-07-01 4. enrollment: 40 → 10 participants 5. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT05130255 updates: 1. status: RECRUITING → TERMINATED 2. completion date: 2027-04-01 → 2026-03-11 3. primary completion date: 2027-03-01 → 2026-03-11 4. enrollment: 60 → 23 participants 5. enrollment type: ESTIMATED → ACTUAL 6. allocation: NA → NON_RANDOMIZED 7. intervention model: SINGLE_GROUP → SEQUENTIAL 8. masking: NONE → SINGLE

Clinical trial NCT04457284 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-07-01 → 2026-06-17 3. primary completion date: 2026-07-01 → 2026-06-17